Health Canada has approved Caya, a new reusable, single-size diaphragm for over-the-counter sale in Canada.


Caya, diaphragm, women's contraceptive, Kessel Personal Healthcare, Trimedic Supply Network, Health Canada, Paul Gelbfarb, pharmacy








































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Caya diaphragm contraceptive gets OTC OK in Canada

May 5th, 2014

CONCORD, Ontario – Health Canada has approved Caya, a new reusable, single-size diaphragm for over-the-counter sale in Canada.

The women's contraceptive, made by Germany-based Kessel Personal Healthcare, is slated to launch in Canada on May 8, said Trimedic Supply Network Ltd. of Toronto, the product's Canadian supplier.

Trimedic noted that Caya's Canadian launch continues the expansion of contraceptive options for women, particularly nonhormonal options like diaphragms that have been limited in Canada and the United States.

Plans call for Caya's Canadian distribution to initially be through pharmacy wholesalers such as McKesson and other distribution partners that will also sell direct to doctors and naturopaths, according to Trimedic.

"Within the next 12 months, we expect the Caya to be the first-ever female contraceptive available on the retail shelf at all pharmacies across Canada," stated Trimedic's Paula Gelbfarb. She added that Trimedic is currently in negotiations with several large retailers but is considering an exclusive deal with national retail banner.

Caya has an anatomically shaped, contoured rim that allows coverage of the cervix, according to Trimedic. Diaphragm guidelines recommend applying contraceptive gel for added protection and spreading gel on the rim to facilitate insertion. Caya can be used over again for up to two years.

Canada's approval of Caya follows European regulatory approval of the SILCS diaphragm last year, which opened the way for its commercial debut, Trimedic said.

Kessel, Caya's manufacturer, is planning for additional market registrations, including a regulatory submission to the U.S. Food and Drug Administration for clearance to market the diaphragm in the United States, Trimedic added.

Advertisement